Mark Bromberg
Motor Neuron Disease in Adults
Mark Bromberg
Motor Neuron Disease in Adults
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Motor Neuron Disease reviews new information from 1998 as it applies to all aspects of motor neuron disease. Articles included use evidence-based methods to ensure that the new information is solid and advances the topic. The book can be used by anyone who provides any type of care to ALS patients.
Andere Kunden interessierten sich auch für
Novel Aspects on Motor Neuron Disease84,99 €
Michael Strong (ed.)Dementia and Motor Neuron Disease140,99 €
Non-motor Symptoms of Parkinson's Disease211,99 €
Mark L LatashSeminars in Motor Control132,99 €
Advances in Motor Neuroprostheses142,99 €
The Basal Ganglia: Novel Perspectives on Motor and Cognitive Functions130,99 €
Cellular Imaging Techniques for Neuroscience and Beyond102,99 €-
-
-
Motor Neuron Disease reviews new information from 1998 as it applies to all aspects of motor neuron disease. Articles included use evidence-based methods to ensure that the new information is solid and advances the topic. The book can be used by anyone who provides any type of care to ALS patients.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press
- Seitenzahl: 368
- Erscheinungstermin: 13. November 2014
- Englisch
- Abmessung: 262mm x 183mm x 21mm
- Gewicht: 934g
- ISBN-13: 9780199783113
- ISBN-10: 019978311X
- Artikelnr.: 47865063
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Oxford University Press
- Seitenzahl: 368
- Erscheinungstermin: 13. November 2014
- Englisch
- Abmessung: 262mm x 183mm x 21mm
- Gewicht: 934g
- ISBN-13: 9780199783113
- ISBN-10: 019978311X
- Artikelnr.: 47865063
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Marc B. Bromberg, MD, PhD Professor of Neurology University of Utah Salt Lake City, Utah.
* Introduction to "Motor Neuron Disease"
* 1. History of the Recognition of Motor Neuron Disease
* 2. Nomenclature and Classification of Motor Neuron Disease
* 3. Clinical Anatomy, Physiology and Pathology of Motor Neuron Disease
* 4. Clinical Features of Motor Neuron Disease
* 5. Frontotemporal Dysfunction and Dementia in Amyotrophic Lateral
Sclerosis
* 6. Laboratory Tests for Motor Neuron Disease
* 7. Biomarkers for Motor Neuron Disease
* 8. Imaging in Motor Neuron Disease
* 9. Diagnostic Criteria for Motor Neuron Disease
* 10. Differential Diagnosis of Motor Neuron Disease
* 11. Progression of Motor Neuron Disease
* 12. Epidemiology of Amyotrophic Lateral Sclerosis
* 13. Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal
Dementia:
* 14. Genome-wide Screening to Identify ALS-associated Genes:
* 15. Pathology of ALS and Frontotemporal Lobar Degeneration:
* 16. Convergence and Divergence in ALS Syndrome: Genetics, Molecular
Pathways and Molecular Mechanisms:
* 17. Immunologic Aspects of Amyotrophic Lateral Sclerosis:
* 18. Cyanobacteria, ALS, and the BMAA Hypothesis
* 19. Animal models of Adult Motor Neuron Disease
* 20. Multidisciplinary Clinics and Practice Parameters/Guidelines
* 21. Allied Health and Other Providers
* 22. Respiratory Assessment and Management
* 23. Nutritional Assessment and Management
* 24. Communication Assessment and Management
* 25. Psychological and Psychiatric Assessment and Management
* 26. Symptoms and Management
* 27. Intimacy, Sexuality and Pregnancy
* 28. Quality of Life
* 29. Caregiver Issues
* 30. End of Life Care
* 31. Costs of ALS Care:
* 32. Clinical Trial Designs in ALS:
* 33. Stem Cell Therapy for Motor Neuron Disease:
* 1. History of the Recognition of Motor Neuron Disease
* 2. Nomenclature and Classification of Motor Neuron Disease
* 3. Clinical Anatomy, Physiology and Pathology of Motor Neuron Disease
* 4. Clinical Features of Motor Neuron Disease
* 5. Frontotemporal Dysfunction and Dementia in Amyotrophic Lateral
Sclerosis
* 6. Laboratory Tests for Motor Neuron Disease
* 7. Biomarkers for Motor Neuron Disease
* 8. Imaging in Motor Neuron Disease
* 9. Diagnostic Criteria for Motor Neuron Disease
* 10. Differential Diagnosis of Motor Neuron Disease
* 11. Progression of Motor Neuron Disease
* 12. Epidemiology of Amyotrophic Lateral Sclerosis
* 13. Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal
Dementia:
* 14. Genome-wide Screening to Identify ALS-associated Genes:
* 15. Pathology of ALS and Frontotemporal Lobar Degeneration:
* 16. Convergence and Divergence in ALS Syndrome: Genetics, Molecular
Pathways and Molecular Mechanisms:
* 17. Immunologic Aspects of Amyotrophic Lateral Sclerosis:
* 18. Cyanobacteria, ALS, and the BMAA Hypothesis
* 19. Animal models of Adult Motor Neuron Disease
* 20. Multidisciplinary Clinics and Practice Parameters/Guidelines
* 21. Allied Health and Other Providers
* 22. Respiratory Assessment and Management
* 23. Nutritional Assessment and Management
* 24. Communication Assessment and Management
* 25. Psychological and Psychiatric Assessment and Management
* 26. Symptoms and Management
* 27. Intimacy, Sexuality and Pregnancy
* 28. Quality of Life
* 29. Caregiver Issues
* 30. End of Life Care
* 31. Costs of ALS Care:
* 32. Clinical Trial Designs in ALS:
* 33. Stem Cell Therapy for Motor Neuron Disease:
* Introduction to "Motor Neuron Disease"
* 1. History of the Recognition of Motor Neuron Disease
* 2. Nomenclature and Classification of Motor Neuron Disease
* 3. Clinical Anatomy, Physiology and Pathology of Motor Neuron Disease
* 4. Clinical Features of Motor Neuron Disease
* 5. Frontotemporal Dysfunction and Dementia in Amyotrophic Lateral
Sclerosis
* 6. Laboratory Tests for Motor Neuron Disease
* 7. Biomarkers for Motor Neuron Disease
* 8. Imaging in Motor Neuron Disease
* 9. Diagnostic Criteria for Motor Neuron Disease
* 10. Differential Diagnosis of Motor Neuron Disease
* 11. Progression of Motor Neuron Disease
* 12. Epidemiology of Amyotrophic Lateral Sclerosis
* 13. Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal
Dementia:
* 14. Genome-wide Screening to Identify ALS-associated Genes:
* 15. Pathology of ALS and Frontotemporal Lobar Degeneration:
* 16. Convergence and Divergence in ALS Syndrome: Genetics, Molecular
Pathways and Molecular Mechanisms:
* 17. Immunologic Aspects of Amyotrophic Lateral Sclerosis:
* 18. Cyanobacteria, ALS, and the BMAA Hypothesis
* 19. Animal models of Adult Motor Neuron Disease
* 20. Multidisciplinary Clinics and Practice Parameters/Guidelines
* 21. Allied Health and Other Providers
* 22. Respiratory Assessment and Management
* 23. Nutritional Assessment and Management
* 24. Communication Assessment and Management
* 25. Psychological and Psychiatric Assessment and Management
* 26. Symptoms and Management
* 27. Intimacy, Sexuality and Pregnancy
* 28. Quality of Life
* 29. Caregiver Issues
* 30. End of Life Care
* 31. Costs of ALS Care:
* 32. Clinical Trial Designs in ALS:
* 33. Stem Cell Therapy for Motor Neuron Disease:
* 1. History of the Recognition of Motor Neuron Disease
* 2. Nomenclature and Classification of Motor Neuron Disease
* 3. Clinical Anatomy, Physiology and Pathology of Motor Neuron Disease
* 4. Clinical Features of Motor Neuron Disease
* 5. Frontotemporal Dysfunction and Dementia in Amyotrophic Lateral
Sclerosis
* 6. Laboratory Tests for Motor Neuron Disease
* 7. Biomarkers for Motor Neuron Disease
* 8. Imaging in Motor Neuron Disease
* 9. Diagnostic Criteria for Motor Neuron Disease
* 10. Differential Diagnosis of Motor Neuron Disease
* 11. Progression of Motor Neuron Disease
* 12. Epidemiology of Amyotrophic Lateral Sclerosis
* 13. Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal
Dementia:
* 14. Genome-wide Screening to Identify ALS-associated Genes:
* 15. Pathology of ALS and Frontotemporal Lobar Degeneration:
* 16. Convergence and Divergence in ALS Syndrome: Genetics, Molecular
Pathways and Molecular Mechanisms:
* 17. Immunologic Aspects of Amyotrophic Lateral Sclerosis:
* 18. Cyanobacteria, ALS, and the BMAA Hypothesis
* 19. Animal models of Adult Motor Neuron Disease
* 20. Multidisciplinary Clinics and Practice Parameters/Guidelines
* 21. Allied Health and Other Providers
* 22. Respiratory Assessment and Management
* 23. Nutritional Assessment and Management
* 24. Communication Assessment and Management
* 25. Psychological and Psychiatric Assessment and Management
* 26. Symptoms and Management
* 27. Intimacy, Sexuality and Pregnancy
* 28. Quality of Life
* 29. Caregiver Issues
* 30. End of Life Care
* 31. Costs of ALS Care:
* 32. Clinical Trial Designs in ALS:
* 33. Stem Cell Therapy for Motor Neuron Disease:







